2024 |
Design Therapeutics Inc
|
Lead Independent Director |
- |
- |
2024 |
CRISPR Therapeutics AG
|
Independent Director |
- |
- |
2023 |
CRISPR Therapeutics AG
|
Independent Director |
542.6 K |
-10.8 % |
2023 |
Nkarta Inc
|
Independent Director |
126.3 K |
- |
2023 |
Design Therapeutics Inc
|
Lead Independent Director |
95.7 K |
-42.9 % |
2022 |
CRISPR Therapeutics AG
|
Independent Director |
608.4 K |
-24.8 % |
2022 |
Design Therapeutics Inc
|
Independent Director |
167.5 K |
-23.4 % |
2022 |
Nkarta Inc
|
Independent Director |
- |
- |
2021 |
CRISPR Therapeutics AG
|
Independent Director |
809.5 K |
36.1 % |
2021 |
Nkarta Inc
|
Independent Director |
310.0 K |
122.3 % |
2021 |
Design Therapeutics Inc
|
Independent Director |
218.7 K |
- |
2020 |
CRISPR Therapeutics AG
|
Independent Director |
594.9 K |
31.6 % |
2020 |
Nkarta Inc
|
Independent Director |
139.5 K |
- |
2020 |
Design Therapeutics Inc
|
Independent Director |
- |
- |
2019 |
CRISPR Therapeutics AG
|
Independent Director |
451.9 K |
-29.8 % |
2019 |
Nkarta Inc
|
Independent Director |
- |
- |
2019 |
Progyny Inc
|
Director |
- |
- |
2018 |
CRISPR Therapeutics AG
|
Independent Director |
643.8 K |
256.7 % |
2018 |
Progyny Inc
|
Director |
- |
- |
2017 |
CRISPR Therapeutics AG
|
Independent Director |
180.5 K |
-40.9 % |
2016 |
CRISPR Therapeutics AG
|
Independent Director |
305.3 K |
- |
2015 |
CRISPR Therapeutics AG
|
Independent Director |
- |
- |